These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 25433500)
1. Serum autoantibodies in the early detection of esophageal cancer: a systematic review. Zhang H; Xia J; Wang K; Zhang J Tumour Biol; 2015 Jan; 36(1):95-109. PubMed ID: 25433500 [TBL] [Abstract][Full Text] [Related]
2. Systematic review: serum autoantibodies in the early detection of gastric cancer. Werner S; Chen H; Tao S; Brenner H Int J Cancer; 2015 May; 136(10):2243-52. PubMed ID: 24615018 [TBL] [Abstract][Full Text] [Related]
3. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255 [TBL] [Abstract][Full Text] [Related]
4. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876 [TBL] [Abstract][Full Text] [Related]
5. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers. Oshima Y; Shimada H; Yajima S; Nanami T; Matsushita K; Nomura F; Kainuma O; Takiguchi N; Soda H; Ueda T; Iizasa T; Yamamoto N; Yamamoto H; Nagata M; Yokoi S; Tagawa M; Ohtsuka S; Kuwajima A; Murakami A; Kaneko H J Gastroenterol; 2016 Jan; 51(1):30-4. PubMed ID: 25906289 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum tumor-associated autoantibodies in esophageal cancer. Xiao K; Ma X; Wang Y; Zhu C; Guo L; Lu R Biomark Med; 2021 Oct; 15(15):1333-1343. PubMed ID: 34541870 [No Abstract] [Full Text] [Related]
7. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma. Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952 [TBL] [Abstract][Full Text] [Related]
8. Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma. Liu WL; Zhang G; Wang JY; Cao JY; Guo XZ; Xu LH; Li MZ; Song LB; Huang WL; Zeng MS Biochem Biophys Res Commun; 2008 Oct; 375(3):440-5. PubMed ID: 18722351 [TBL] [Abstract][Full Text] [Related]
9. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection. Dumstrei K; Chen H; Brenner H Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568 [TBL] [Abstract][Full Text] [Related]
11. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma. Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995 [TBL] [Abstract][Full Text] [Related]
12. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis. Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246 [TBL] [Abstract][Full Text] [Related]
13. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma. Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295 [TBL] [Abstract][Full Text] [Related]
14. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Chen H; Werner S; Tao S; Zörnig I; Brenner H Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820 [TBL] [Abstract][Full Text] [Related]
15. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer. Jin Y; Guan S; Liu L; Sun S; Lee KH; Wei J Asia Pac J Clin Oncol; 2015 Dec; 11(4):e37-41. PubMed ID: 24811068 [TBL] [Abstract][Full Text] [Related]
16. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma. Li L; Liu M; Lin JB; Hong XB; Chen WX; Guo H; Xu LY; Xu YW; Li EM; Peng YH Dis Markers; 2017; 2017():2534648. PubMed ID: 28298808 [TBL] [Abstract][Full Text] [Related]
18. Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum. Kilic A; Schuchert MJ; Luketich JD; Landreneau RJ; Lokshin AE; Bigbee WL; El-Hefnawy T J Thorac Cardiovasc Surg; 2008 Jul; 136(1):199-204. PubMed ID: 18603076 [TBL] [Abstract][Full Text] [Related]
19. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma. Ye L; Guan S; Zhang C; Lee KH; Sun S; Wei J; Liu B Tumour Biol; 2013 Jun; 34(3):1873-7. PubMed ID: 23483489 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. Xu YW; Peng YH; Xu LY; Xie JJ; Li EM World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]